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Adenoviral vectors have a poor record of transgene delivery efficiency through physical barriers such as the epithelium or endothelium.
We report here the construction of an adenoviral vector that has the capability to be transported across polarized epithelial monolayers of
Caco-2 cells (a colon carcinoma cell line) by transcytosis. This transcytosis is transferrin receptor (TfR)-mediated with use of a bifunctional
adaptor, soluble coxsackie adenovirus receptor (sCAR)-Tf, and is both temperature and iron dependent. Under experimental conditions, the
adenoviral transcytosis was inhibited by pretreatment of Caco-2 cells with colchicine, an inhibitor of transcytosis, and was not enhanced by
pretreatment with Brefeldin A (BFA), an enhancer of transcytosis. In these Caco-2 cells, the transcytosis rate was 0.3 F 1.3% (SD). The
transcytosed adenoviruses remain biologically functional. These data suggest the potential clinical benefit under conditions where drug
delivery is a challenge, such as within the airway epithelium, at the bladder lumen urothelial cell interface, and across the blood–brain barrier
for clinical treatment of lung, urogenital, and brain disorders, respectively, by adenoviral transcytosis of transgene delivery.
D 2004 Elsevier Inc. All rights reserved.Keywords: Caco-2 cells; TfR; Adenovirus
Introduction integrin, facilitates virus internalization into these sameAdenoviral vectors are widely used in gene delivery
because they have the capacity to infect a broad range of
different cell types. Recent studies have identified a 46-
kDa host cell membrane protein, coxsackie adenovirus
receptor (CAR), that serves as the primary receptor for
Ad serotypes 2 and 5 as well as coxsackie B virus
attachment to cells (Bergelson et al., 1997; Tomko et al.,
1997). Interaction of Ad with a second receptor, av0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.04.021
Abbreviations: bp, base pairs; CMV, cytomegalovirus; Tf, transferrin;
TfR, transferrin receptor; vp, viral particles.
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lenges to the efficient use of Ad vectors for in vivo gene
delivery exist, including the fact that transgenes are diffi-
cult to deliver via Ad vectors into airway lumina (Pickles
et al., 1998), at bladder lumen urothelial cell interfaces
(Chester et al., 2003), and across the blood–brain barrier
(Butt et al., 1990; Crone and Olesen, 1982) because of
epithelial and endothelial cell barriers. These lining cells,
which are joined together by complex tight intercellular
junctions, form a continuous wall against the passive
paracellular movement of substances. This is an obstacle
for successful gene therapy for the treatment of many
disorders including neoplasia.
Receptor-mediated transcytosis can be utilized as a path-
way for achieving specific delivery of protein moieties and
their peptide constituents across cellular barrier such as the
endothelium or epithelium (Shah and Shen, 1996; Tan et al.,
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receptor (pIgR), an integral membrane protein, is required for
transcytosis of polymeric immunoglobulin (pIg) including
IgA and IgM across mucosal epithelial cell barriers (Mostov
and Kaetzel, 1999). After synthesis by plasma cells, poly-
meric IgA and IgM are commonly in the lamina propria of the
mucosal membrane; they bind covalently to pIgR expressed
on the basolateral surface of the epithelial layer. The pIg–
pIgR complex is then transported via a series of endosomal
compartments across the epithelium to the mucosal surface,
where it is released as mucosal secretions (Song et al., 1994;
Zhang et al., 2000). Another example of transcytosis relevant
to the proposed model vector is transferrin (Tf)–transferrin
receptor (TfR)-mediated iron uptake (Kishimoto and Tavas-
soli, 1987; Ma et al., 2002; Roberts et al., 1992). Iron is
essential for almost all organisms, fulfilling a variety of
biological functions. In human, defects in iron absorption
and utilization lead to iron deficiency, overload disorders, and
certain neurodegenerative disorders (Andrews, 1999; Lieu et
al., 2001). The disease is characterized by inappropriate
control of intestinal iron absorption, resulting in excessive
accumulation of iron in organs such as the liver, heart, and
pancreas, eventually leading to multi-organ dysfunction
(Anderson, 1996). In the intestine, transcytosis of TfR
appears to be important in iron homeostasis via regulation
of iron regulatory proteins (IRPs) and iron-responsive ele-
ments (IREs) at the posttranscriptional level (Hentze and
Kuhn, 1996; Klausner et al., 1993; Theil, 1994). The TfR has
been found in blood cells, hepatocytes, intestinal cells,
monocyte, brain, the blood–brain barrier, and also some
insects and bacteria (Lonnerdal and Iyer, 1995; Schryvers
et al., 1998). The major pathway for cellular iron uptake is
through internalization of the complex of iron-bound
TfTfRHFE (Feder et al., 1998; Gross et al., 1998; Parkkila
et al., 1997). HFE is the product of the gene that was
designated HLA-H that is mutated in >80% of hereditary
hemochromatosis patients. Iron is released from transferrin as
the result of the acidic pH in the endosome and is then
transported to the cytosol by DMT1, the iron transporter
(Canonne-Hergaux and Gros, 2002; Garrick et al., 2003;
Lam-Yuk-Tseung et al., 2003). The iron is then utilized as a
cofactor by heme and ribonucleotide reductase or stored as
ferritin. Interestingly, transferrin has been thought of as a
‘‘delivery system’’ with many benefits and has been widely
applied as a targeting ligand in the active targeting of
anticancer agents, proteins, and genes to primary proliferat-
ing malignant cells that overexpress transferrin receptors
(Friden, 1994; Quick et al., 2000; Singh, 1999).
The idea of viruses being transported across barriers is
feasible. Recent studies suggest that the transcytosis of
HIV by epithelial cells plays an important role in HIV
transmission across an intact epithelial barrier (Banks et
al., 2001; Hocini et al., 2001). A group from Taiwan
reported that Japanese encephalitis virus is transported
across the cerebral blood vessels by endocytosis in mouse
brain (Liou and Hsu, 1998). However, there have beenno publications to date describing adenovirus transcytosis
via either pIgR or TfR. We expect that if an adenoviral
vector could cross epithelial or endothelial cells by
transcytosis, it would be beneficial for gene delivery
clinical applications.
In this study, (1) Caco-2 cells, which overexpressed
transferrin receptor, were used as targeting cells; (2) a
fusion protein, soluble CAR (sCAR)-Tf, was used as a
bifunctional adaptor; and (3) an adenoviral vector,
AdGL3BCMVLuc, which is a non-replicative adenovirus
containing the luciferase reporter gene driven by a cyto-
megalovirus (CMV) promoter, was used as a vehicle for
examining cellular transport across a polarized monolayer.
The data showed that this adenoviral vector construct is
transported across Caco-2 cells by transferrin receptor-
mediated transcytosis. Further, the data demonstrated that
transcytosed adenoviruses after crossing the polarized
monolayer of Caco-2 cell remained biologically functional.
This promising evidence of gene delivery across the
epithelium by transcytosis via adenoviral vectors has
potential significant clinical application in human cancer
gene therapy.Results
Design and generation of the fusion protein, sCAR-Tf
As discussed in the Introduction, a bifunctional adaptor
was used to facilitate Ad transcytosis into epithelial cells in
this study. This bifunctional adaptor has two functional
domains. One binds to adenovirus, the other to the receptor
on the cell surface. It allows adenovirus entry into epithe-
lial cells through a transcytosis response receptor, transfer-
rin receptor (TfR), bypassing coxsackie adenovirus
receptor (CAR), the native receptor used by Ad serotypes
2 and 5 for attaching to the cell surface. A fusion protein
construct for the sCAR-EGF protein was used as a
backbone, and we successfully replaced the region encod-
ing the EGF protein by a full-length cDNA of human
transferrin, which was amplified from a human transferrin
cDNA clone, pTfR27A. The sCAR-Tf fusion protein clone
was termed pFBsCAR6hTf (Fig. 1A) and contains a pPolh
promoter, a human CAR ectodomain coding region, six
histidine tag, a short flexible linker (SASASASAPGS),
2040 bp of human transferrin cDNA, and a poly-A signal.
The internal six His tag was used for rapid and efficient
purification via immobilized metal ion affinity chromatog-
raphy, Ni-NTA Sepharose as described in Materials and
methods. A short flexible linker was used for effectively
separating the two domains of the bifunctional fusion
protein. To produce sCAR-Tf, recombinant baculoviruses
containing the genes of interest were created and used to
infect cells. Infection of High Five cells with this recom-
binant baculoviruses resulted in a high level of sCAR-Tf
expression in both cells and supernatant.
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The proteins produced with the baculovirus system were
verified by Western blotting and the results shown in Fig.
Z.B. Zhu et al. / Viro1181B. In panel I, a primary antibody, mAb anti-sCAR, and
goat anti-mouse IgG secondary antibody conjugated to
horseradish peroxidase (HRP) were used. The sCAR-Tf
protein was detected both in the cell lysate and in the
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of approximately 120 kDa both in cell lysate and superna-
tant. The fusion protein secreted into the supernatant was
detected day 3 postinfection, and the amount was less than
that derived from the cell lysate. A positive control, sCAR,
is shown in the first lane and had a molecular mass of 30
kDa. In panel II, the primary antibody used was anti-Tf
instead of anti-sCAR for detecting the Tf domain. The
results were similar to panel I, except the positive control
sCAR could not be detected, because primary antibody anti-
Tf was unable to bind to the sCAR domain. In both panels,
the two negative control samples, uninfected cell lysate and
PBS, were appropriately negative. These data demonstrated
that we were able to obtain preparative amounts of homo-
geneously purified sCAR-Tf fusion protein for subsequent
analysis by using the baculovirus expression system and Ni-
NTA affinity purification.
The binding between purified Ad5knob and the fusion
proteins sCAR-Tf purified from both the cell lysate and the
supernatant was tested by ELISA and the data shown in Fig.
1C. This assay demonstrated that the fusion protein sCAR-
Tf from the supernatant was bound to purified Ad5knob,
which was coated on a 96-well ELISA plate, with a higher
efficiency (A405 nm = 0.84) than that from the cell lysate
(A405 nm = 0.17). Both negative controls had very low OD
values (<0.1 at A405 nm). Therefore, the fusion protein
sCAR-Tf purified from the supernatant was used in all
additional experiments in this study.
Internalization of adenovirus via transferrin receptor on
Caco-2 cell surfaces
AdGL3BCMVLuc contains a luciferase reporter gene
driven by the CMV promoter and is a non-replicate adeno-
viral vector, because the gene (E1) related to virus replication
was deleted. When Caco-2 cells were infected with Ads, the
expression level of the luciferase reporter gene corresponded
to the Ad level at entry into the cells. We, thus, measured the
luciferase activity from the cell lysate to evaluate the amount
of Ad entry into the cells through the transferrin receptor
compared to the native receptor CAR. The data are shown in
Fig. 2A. In lane A, Ad infection was driven by the CMV
promoter into Caco-2 cells via CAR and set at 100% relativeFig. 1. Characterization of sCAR-Tf fusion proteins. (A) Construction of the fus
baculovirus expression vector. Expression is driven from the polyhedrin promoter (
terminus of the CAR domain (238 aa). To construct the sCAR-Tf protein, hum
(SASASASAPGS) and tagged with His6. (B) Analysis of the presence of recombin
-His6-tagged proteins expressed in insect cells were purified on a Ni-NTA-Sephar
analyzed by electrophoresis on a 12% polyacrylamide gel under denaturing condi
panel II, mAb antihuman-transferrin was used as the primary antibody. A goat a
antibody in both panels I and II. The negative controls included the protein purifie
molecular masses of marker protein in kilodaltons. (C) Analysis of the interaction b
Ad5knob coated on an ELISA plate was incubated with the fusion protein sCAR-T
with antihuman transferrin mAb as the primary antibody, and goat anti-mouse IgG
represents the mean F SD of triplicate determinations. Negative controls were pelight units (RLU). In lane B, Ads were dramatically less able
to infect Caco-2 cells when the CARs were blocked with 5
Ag/ml of Ad5knob (0.3% RLU compared to lane A). In lane
C, the Ads entered the cells by the bifunctional adaptor
sCAR-Tf, the luciferase level was lifted to 1.2% as compared
to lane A. In lane D, the conditions are identical as in C except
the sCAR-Tf was preincubated with mAb (1:1000 dilution)
against human transferrin. Luciferase activity was seen to be
reduced to 0.8% compared to lane A. This indicates that the
endocytosis of adenovirus was partially inhibited by the mAb
with an inhibition rate of 33.3%. Because mAb antihuman
transferrin did not efficiently inhibit the binding between the
adaptor, sCAR-Tf, and TfR, and did not abolish the internal-
ization of Ad, we used the apo-transferrin protein to block
TfR. The results are shown in Fig. 2B. Apo-transferrin
efficiently inhibited internalization of Ads into Caco-2 cells
at an inhibition rate of 70%when the dose reached 6 Ag/ml of
transferrin, and the inhibition curve was dose responsive to
apo-transferrin protein. The data verified Ad internalization
into Caco-2 cells did occur through TfRwhen the native CAR
pathway was blocked.
Iron effects on binding of Tf to TfR
The fundamental role of transferrin is to control the
levels of free iron (Fe2+) in body fluids by binding,
sequestering, and transporting Fe3+ irons, which helps to
maintain the availability of iron and prevent the deposition
of insoluble ferric hydroxide aggregates. Iron binding to Tf
may maintain the conformation of Tf needed for its inter-
action with TfR. To test this hypothesis, 108 vp
AdGL3BCMV was preincubated with 500 ng of the fusion
protein sCAR-Tf, and a series of increasing doses of iron (0,
0.1, 1, 1, 10, 100 AM, or 1 mM) at 37 jC for 15 min in 20
Al PBS was given to verify the role of iron during internal-
ization of the Ads. The results showed (Fig. 3) that iron was
not essential, but rather was related to the binding between
Tf and TfR. Endocytosis mediated by Tf–TfR reached a
level 480,000 RLU in the absence of iron (in lane 1).
However, although 10 AM of iron concentration almost
doubled the internalization level of Ads to 830,000 RLU
(in lane 4), this response was lost at higher doses of iron
exposure (lane 5 and 6).ion protein sCAR-Tf. The gene coding for sCAR-Tf was constructed in a
pPolh). A His6 tag was introduced for purification purposes into the carboxy
an Tf (679 aa) was fused with the CAR ectodomain by a flexible linker
ant sCAR-Tf protein by Western blotting. Soluble CAR-His6- and sCAR-Tf
ose column in cell lysate or supernatant postinfection days 2, 3, and 4, and
tions. In panel I, the mAb anti-sCAR was used as the primary antibody; in
nti-mouse IgG conjugated to horseradish peroxidase was used as a second
d from uninfected insect cells and PBS. Numbers on the left sides indicate
etween recombinant protein, sCAR-Tf, and Ad5knob by ELISA. A purified
f purified from lysate or supernatant. Bound fusion protein was then detected
conjugated to horseradish peroxidase as the secondary antibody. Each point
rformed without the use of primary antibodies. O.D., optical density.
Fig. 3. Iron effect on Tf binding to TfR. AdGL3BCMV was pretreated with
the fusion protein sCAR-Tf and exposed to an increasing amount of iron
(FeCl3, 0, 0.1, 1, 10, 100, and 1000 AM). Then the mixture was added to the
basal chamber and the luciferase activity was measured as RLU in the cell
lysate after 24-h incubation.
Fig. 2. Endocytosis of adenoviruses into Caco-2 cells via TfR. (A)
Endocytosis of AdGL3BCMV into Caco-2 cells was detected by luciferase
activity reported as relative light units (RLU). Lane A, 108 vp of
AdGL3BCMV was added to the basal chamber only; lane B, before adding
108 vp of AdGL3BCMV to the basal chamber, CARs on the cell surface
were blocked with Ad5knob; lane C, same as lane B, the AdGL3BCMV
was pretreated with 500 ng of sCAR-Tf as described in the Materials and
methods; lane D, antihuman transferrin mAb was used to block the Tf
domain in the fusion protein. Lane A was set as 100% RLU. (B) Inhibition
curve of adenovirus endocytosis through a tight Caco-2 epithelial barrier by
a human apo-transferrin protein. The CAR-blocked Caco-2 cells were
incubated with increasing amounts of apo-transferrin before adding the
mixture of Ads and sCAR-Tf.
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We have demonstrated that the internalization of
AdGL3BCMVLuc into Caco-2 cells via TfR on the surface
of the cells occurs. We tried to investigate whether free
adenoviral particles were capable of transcytosis through the
Caco-2-polarized monolayer via TfR with a bifunctional
adaptor sCAR-Tf. The data are shown in Fig. 4A. The Ads
were preincubated with sCAR-Tf at 37 jC for 15 min,
leading to the domain of sCAR of the adaptor binding to the
knob of Ad. The mixture was added into the basal chamber
of the transwell plate after the cells had previously beenblocked with Ad5knob. The medium in the apical chamber
was collected at different time points, and the copy number
of the Ad E4 gene was detected by quantitative real-time
PCR. The copy number of adenoviruses detected in the
apical side was increased 500-fold 6 h postincubation.
Adenoviruses detected on the apical side were not second-
ary to leakage of the Caco-2 cell monolayers because the
copy number dropped more than 10-fold if the bifunctional
adaptor sCAR-Tf was excluded from the transcytosis sys-
tem. This suggests that adenoviruses transferred to the
apical chamber from the basal chamber via a Tf receptor-
mediated mechanism.
Also, the transcytosis was temperature related, similar to
that noted previously in the literature (Hocini et al., 2001).
Fig. 4B shows transcytosis of free viruses was inhibited by
decreasing temperature. Twenty percent of transcytosis was
inhibited by incubating at 15 jC, and more than 90% was
inhibited at 4 jC. The possibility that the level of trans-
cytosed Ads at 4 jC incubation might represent background
leakage of the polarized monolayers of Caco-2 cells cannot,
however, be completely excluded.
Enhancement and inhibition of transcytosis
An experiment was performed to further verify adeno-
virus transcytosis in a Caco-2-polarized monolayer via TfR.
We set the transcytosis rate as 100% in the transcytosis
group (Lane A) in which CAR on the cell surface was
blocked with Ad5knob, and the AdGL3BCMVLuc was
pretreated with bifunctional adaptor sCAR-Tf. Seventy
percent and 90% of transcytosis rate of Ads, respectively,
were inhibited when TfR was blocked with either human
apo-transferrin (6 Ag/ml) (lane D) or the Ads were without
the bifunctional adaptor sCAR-Tf (lane F). The data further
verify that the transcytosis of adenoviruses in a Caco-2-
polarized monolayer is TfR-mediated. Transcytosis rates in
Caco-2 cells were also partially inhibited by treatment with
Fig. 4. Characterization of transcytosis of free adenoviruses through a tight
monolayer of Caco-2 cells. (A) Kinetics of transcytosis of free adenovirus
with bifunctional adaptor sCAR-Tf (solid circles) and without sCAR-Tf
(open circles). Caco-2 cells (5  104) were plated in a 12-well transwell
plate. The CARs on the cell surface were blocked with Ad5knob and 108 vp
AdGL3BCMV with or without sCAR-Tf was added into the basal chamber.
The results are expressed as the amount of E4 copy number detected by
real-time PCR in the apical chamber as a function of time. (B) Temperature
dependency of transcytosis. Transcytosis of free adenovirus through a
Caco-2 cell monolayer was assessed at 37, 15, and 4 jC by measuring the
amount of E4 gene by real-time PCR in the apical chamber after 6 h of
incubation. Results are expressed as the mean F the standard deviation of
three separate experiments.
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to lane A, respectively. However, it was not evident that the
transcytosis of adenovirus was enhanced by pretreating
cells with 1.6 Ag/ml Brefeldin A (BFA, lane B), which
was previously reported to have been seen during TfR
transcytosis.
Adenovirus biological function after transcytosis
Cellular uptake of iron from transferrin occurs via
transferrin receptor-mediated endocytosis. Diferric transfer-
rin is bound to the membrane-bound transferrin receptor and
internalized via receptor-mediated endocytosis into endo-
somes. Upon acidification (pH 5.5), iron is released and
then transported by the iron transporter DMT1 into the
cytoplasm. To verify whether the acidification (pH 5.5)during transcytosis destroys transcytosed Ads or affects
their biological function, we collected the medium from
the apical chamber after adding AdGL3BCMVLuc into the
basal chamber and incubating for 6 h at 37 jC. The medium
was used to infect 293 cells as described in Materials and
methods. After 24-h incubation at 37 jC, luciferase activ-
ities were measured. The luciferase activity in the trans-
cytosis group, in which the Ads were pretreated with
bifunctional adaptor (sCAR-Tf), was much higher (8 
106 RLU F SD, n = 6) than that in the non-transcytosis
group with a significant difference (P < 0.01). The data
demonstrate that the acidification in endosomes does not
affect the function of the transcytosed adenoviruses during
transportation from the basal chamber into the apical cham-
ber via a Tf–TfR interaction.Discussion
Adenoviral vectors possess several attributes that render
them useful gene delivery vehicles for systemic gene
therapy. In particular, the in vivo transduction efficiencies
achievable with these agents are greater than with currently
available alternative vector system (Akusjarvi, 1993).
However, the efficacy of delivery of adenoviral vector
passing through the epithelium and endothelium is very
low due to the physical barriers described above. The
purpose of these studies was to characterize the ability of
adenoviruses to cross epithelial cells as free viruses. The
use of the Ad vector AdGL3BCMVLuc has a distinct
advantage for this purpose. First of all, this vector is a non-
replicative virus because the response gene (E1) for virus
replication was deleted. The Ad E1 gene contains E1 A
and E1 B genes; E1 A proteins act as major regulators of
early viral transcription and proliferation (Akusjarvi, 1993;
Dyson, 1998), and E1B proteins act as inhibition of
apoptosis and DNA replication (Chinnadurai, 1998; White,
1998). This viral vector can only be replicated in cell lines
in which the E1 gene is complemented, such as the 293
(Graham et al., 1977) or 911 (Fallaux et al., 1996) cell
lines. Non-replicative viruses make it possible to quantita-
tively measure the amount of viruses for endocytosis or
transcytosis without viral amplification in cells. Second,
this vector contains a reporter gene, the luciferase gene,
that is driven by a strong CMV promoter (Yamamoto et
al., 2001). The luciferase activity should be easily and
sensitively measured by a commercial kit even if the Ad of
endocytosis is present in trace amounts. Third, when the
luciferase gene has not yet to be expressed due to a short
incubation time (such as less than 6 h), the copy number
of Ads can be detected by performing an E4 gene assay
using a quantitative real-time PCR technique.
The transcytosis of epithelial or endothelial cells requires
two major receptors previously described, pIgR and TfR.
The human colon adenocarcinoma-derived cell line Caco-2
has the components currently known to be required for iron
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and HFE (Ma et al., 2002). These cells form a polarized
monolayer when grown on a semiporous membrane, allow-
ing demonstration of the transcytosis of adenoviruses from
the basal to the apical chamber. However, the native receptor
of adenoviruses CAR was also highly expressed on the cell
surface of Caco-2 cells (data not shown). Therefore, it was
important in the demonstration of transcytosis to block CAR
completely on the cell surface by use of Ad5knob. The data
shown here indicate that the entry of adenoviral vectors was
inhibited more than 99% when the CARs on cell surface
were blocked with Ad5knob (Fig. 2A).
The technical achievement of Ad retargeting via bispe-
cific molecular complexes has been approached by a variety
of methods, using folate (Kranz et al., 1995), epithelial
growth factor, EGF (Dmitriev et al., 2000), c-erbB-2 onco-
protein (Kashentseva et al., 2002), and av integrin protein
(Wickham et al., 1996). In this regard, abrogation of Ad
native tropism was achieved by the use of the anti-knob
antibody or sCAR conjugated with ligands specific for the
receptor on the target cell surfaces. The advantage of this
technique is that adenoviruses retarget to a new site on the
surface of cells as well as ablate the native tropism of Ad.
We designed a bifunctional adaptor sCAR-Tf that should
ablate the native tropism of Ad with the sCAR domain and
efficiently retarget Ad to TfR on the cell surface with a Tf
domain. This fusion protein was successfully expressed in
High Five cells and purified by Ni-nitrilotriacetic acid
(NTA)-Sepharose. Un-mature fusion protein purified from
cell lysates had a much poorer binding function with either
Ad knob or with TfR compared to the mature fusion protein,
which was purified from the supernatant. It was clear that
the molecular mass of the fusion protein from the superna-
tant is bigger than that from the cell lysate (Fig. 1B) because
of glycosylation. Glycosylation modifications of the protein
are known to play an important rule in maintaining the
function of the protein. As previously reviewed, N-glyco-
sylation is required for full activity of the murine galacto-
sylceramide sulphotrasferase (Eckhardt et al., 2002), and
Chakrabarti et al. (2002) reported that modifications of the
human immunodeficiency virus envelope glycoprotein en-
hance immunogenicity for genetic immunization. It is pos-
sible the glycosylation of the fusion protein sCAR-Tf in the
Golgi network allows the fusion protein to have a biological
secondary structure for both domains that thus enhance their
binding function.
Endocytosis of adenovirus was observed in Fig. 2A,
although the ratio for Ad endocytosis into Caco-2 cells is
relatively modest, only 1.2% in lane C. To verify that
endocytosis is transferrin receptor-mediated, we treated the
fusion protein with mAb anti-Tf for blocking the binding
between Tf and TfR. The data shown in Fig. 2A, lane D,
indicate that only 30% of endocytosis was inhibited by
pretreatment of the fusion protein with mAb anti-Tf.
However, the endocytosis was inhibited 70% by pretreat-
ment of Caco-2 cells with apo-transferrin for blocking TfR.The data thus suggest that the endocytosis of adenovirus
was transferrin receptor-mediated. Monoclonal antibodies
recognize an epitope by few residues, usually 5–10 amino
acids. For example, the monoclonal antibody Syn-1 has
been frequently used for the specific detection of alpha-
synuclein. The epitope for Syn-1 is localized within
residues 91–99 of human alpha-synuclein (nine residues)
(Perrin et al., 2003). Other reports described that ELDWA
(five residues)-epitope-specific monoclonal antibodies in-
hibit HIV-env-mediated syncytium formation (Zhang and
Chen, 2003). We prepared the fusion protein sCAR-Tf
with 679 residues of transferrin including the N- and C-
terminals that include the key domain for TfR binding
(Lawrence et al., 1999). In this regard, we hypothesize that
the mAb anti-Tf, whose recognition site to Tf has not yet
been found, binds to the epitope on Tf in a configuration
that is not close enough to the binding site of TfR that
would result in complete inhibition, thus only partial
inhibition of the endocytosis is observed.
The transferrin receptor (TfR) assists iron uptake into
vertebrate cells through a cycle of endo- and exocytosis of
transferrin (Tf) (Richardson and Ponka, 1997). The TfR has
been found in red blood cells, thyroid cells, hepatocytes,
intestinal cells, monocytes, and brain cell elements. In
malignant cells, there are elevated levels of TfR expression
attributed to the requirement for high levels of iron to
support their growth (Huebers and Finch, 1987). The TfR
is also localized on the endothelial surface of brain capil-
laries that compose the blood–brain barrier (Jefferies et al.,
1984). Generally, transferrin receptors have a higher affinity
to diferric transferrin than apo-transferrin (Sun et al., 1999).
In our data (Fig. 3), the binding affinity was elevated by low
concentrations of iron (the range from 0.1 to 10 AM), but
inhibited at high concentrations (100–1000 AM). The bind-
ing between sCAR-Tf and TfR was detected to a certain
level even if the iron lacked in this system. Therefore, it
seems that binding between Tf’s and TfR benefits from the
presence of iron, but this is not essential.
We investigated whether free adenoviruses in the basal
chamber were capable of transcytosing into the apical
chamber through the polarized monolayer of Caco-2 cells
via TfR and a bifunctional adaptor sCAR-Tf. The data show
in Fig. 4A a significant amount of transcytosis was consis-
tently observed during incubation times from 30 min to 6 h.
At 6 h, the recovery rate in the apical chamber as measured
with real-time PCR for the Ad E4 gene was 0.3 F 0.13%
(mean F the standard error of the mean). This ratio is very
similar to the data published by Hocini et al. (2001) in which
the ratio range was from 0.01 F 0.005% to 0.77% F 0.16%
for recovery rates of transcytosis of different HIV-1 isolates
through a tightly polarized monolayer of human endometrial
cells. The transcytosis was decreased more than 10-fold if
the system contained no bifunctional adaptor. This is strong
evidence that the transcytosis is TfR-mediated via the
bifunctional adaptor sCAR-Tf. Compared to the level of
transcytosis Ads (292 E4 gene copy number), the amount of
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fold higher at the 6-h point. In this regard, Sheff et al. (1999)
demonstrated that the majority of transferrin (65%) was
found to be recycled from the early endosomes within 10
min after internalization in an MDCK cell model. This
suggested that most of internalized Ads may have been
recycled directly back to the basolateral membrane and thus
allowed only a small amount (0.3% in this study) of Ads
across to the apical chamber via transcytosis.
Brefeldin A (BFA) is an agent described to cause an
increase in TfR transcytosis. Shah and Shen (1996) dem-
onstrated a combination of conjugated insulin and BFA
can cause a net 45-fold increase in apical-to-basolateral
transport of insulin across Caco-2 cell monolayers. Wan et
al. (1992) showed data that BFA (1.6 Ag/ml) markedly
enhanced the transcytosis of 125I-labeld Tf (125I-Tf) in both
apical-to-basal and basal-to-apical directions. In our sys-
tem, we did not find the enhanced effect of adenovirus
transcytosis in filter-grown Caco-2 cell monolayers (Fig. 5,
lane B). These data are similar to that described for
transcytosis of albumin in endothelial cells in a Brefeldin
A-independent manner as described by Antohe et al.
(1997). Similarly, BFA did not enhance the transcytosis
of either native horseradish peroxidase (HRP) or mem-
brane-bound HRP-poly (L-lysine) conjugates in a Caco-2
cell monolayer as described by Wan et al. (1992). Colchi-
cine treatment of Caco-2 cells for 4 h depolymerized
99.4% of microtubular tubulin in studies reported by
Gilbert et al. (1991). In our experiments as shown inFig. 5. Effects of enhancer and inhibitor on transcytosis. Transcytosis was
performed as above (CAR entry on cells was blocked with Ad5knob), and
the E4 gene copy number was detected by real-time PCR in the apical
chamber (lane A); parallel Caco-2 cell monolayers were incubated with
Brefeldin A (BFA) 1.6 Ag/ml in the medium of the basal chamber for 5 h at
30 jC before adding Ads into the medium in lane B; Caco-2 cells were
pretreated with 10 AM colchicine for 30 min at 4 jC followed by 10-min
incubation at 37 jC in lane C; Caco-2 cells were pretreated with apo-
transferrin 6 Ag/ml at 37 jC for 20 min in lane D. The mixture of Ads and
sCAT-Tf pretreated with anti-transferrin mAb to block the binding between
Tf and TfR is shown in lane E; and adding AdGL3BCMV directly into the
basal chamber medium without pretreatment of sCAR-Tf is shown in lane
F. The copy number of the Ad E4 gene was detected by real-time PCR in
the apical chamber after 6 h of incubation. Results are expressed as the
mean F the standard deviation in three separate experiments.Fig. 5, lane C, transcytosis was inhibited 30% by the
irreversible depolymerization of microtubules with colchi-
cine. This argues that transcytosis by adenovirus in polar-
ized monolayers of Caco-2 cells is partially mediated by
the active movement of the cytoskeleton.
Most, if not all, mammalian cells are capable of taking
up iron by receptor-mediated endocytosis of diferric trans-
ferrin bound to the transferrin receptor. This process is
complex and can be divided into seven steps, that is, (1)
binding, (2) internalization (endocytosis), (3) acidification,
(4) dissociation, (5) reduction, (6) translocation, and (7)
cytosolic transfer of iron into intracellular compounds such
as ferritin and heme (Aisen, 1998; Qian and Tang, 1995).
Cellular uptake of iron is initiated by the binding of
diferric-transferrin to a specific TfR on the outer face of
the plasma membrane. In fact, it has been demonstrated
that HFE, the protein mutated in hereditary hemochroma-
tosis, and Fe3+-Tf can bind simultaneously to TfR to form
a ternary complex, TfTfRHFE. After endocytosis via
clathrin-coated pits, which eventually bud from the plasma
membrane as membrane-bound vesicles or endosome, the
TfTfRHFE complexes are routed into the endosomal
compartment. Upon maturation and loss of the clathrin
coat, the endosome becomes competent to pump protons in
a process energized by adenosine triphosphate (ATP) and
the endosomal lumen is rapidly acidified to a pH of 5.5
(Dautry-Varsat et al., 1983; Klausner et al., 1983). Iron is
released from Tf. The acidification has been thought to be
essential for the efficient release of iron. This process
should be the same for the transfer and release of adeno-
viruses by transcytosis in the Caco-2 cell model. It is
important to determine if the acidification in the endosome
has the capacity to destroy or disassemble the transferred
adenoviruses or not. We detected luciferase activity
expressed by the AdGL3BCMV vector in 293 cells in
the apical chamber (Fig. 6). These data verified that the
transcytosed adenovirus retains its infectious activity, is
capable of infection of 293 cells, and expressed the
reporter gene luciferase in 293 cells (Fig. 6, lane A). The
luciferase activity was inhibited when the transcytosis
system contained no bifunctional adaptor sCAR-Tf (Fig.
6, lane B), yielding a significant statistical difference (P <
0.01). Again, the data verified that the transcytosis of
adenovirus was Tf–TfR-mediated.
Our data suggest that adenoviruses can be transferred to
an apical chamber from the basal chamber via transcytosis,
which is TfR-mediated and bifunctional adaptor-associated.
Whereas our study has clearly established the feasibility of
exploiting transcytosis to achieve transition of a cellular
barrier, the magnitude of the effect remains limiting. In this
regard, transcytosis rates may be linked to the intrinsic
recycling efficiency of a given pathway. On this basis,
exploiting alternate transcytosis pathways such as P1gR
may allow an enhancement in the functional transcytosis
of Ad. In addition, for a given pathway, transcytosis rates
could also be augmented by maneuvers to increase Ad-
Fig. 6. Adenovirus biological function assay after transcytosis. Trans-
cytosis was carried out as in Fig. 5. Lane A, the medium was collected in
the apical chamber and placed on 293 cells. The luciferase activities from
the 293 cell lysates were measured as RLU 24 h postinfection. The
AdGL3BCMV was pretreated with and without sCAR-Tf in lanes A and
B, respectively. The means represent six separate experiments F the
standard deviations (**P < 0.01).
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levels or enhancement in the affinity between Ad-incorpo-
rated targeting ligand and the target receptor. It is also
noteworthy that Ad capsid modification contributes to
particle fate within cellular endosomes. On this basis, it
should be possible to allow intracellular fate to achieve the
goal of enhanced overall transcytosis.Materials and methods
Cells
Caco-2 cells (American Type Culture Collection, Rock-
ville, MD; passage number 20) were grown on 0.4-Am pore
size polycarbonate filters in transwell chambers (Costar,
Cambridge, MA). Cells were grown at 37 jC in medium
recommended by the suppliers in a humidified atmosphere
of 5% CO2. Monolayers that displayed a transepithelial
electrical resistance (TEER) of 200–300 V/cm2 as mea-
sured with an epithelial volt/ohm meter (EVOM, World
Precision Instruments, West Haven, CT) were used in the
experiments.
Before the experiments, cell monolayers were rinsed
once with serum-free Dulbecco medium containing 1%
nonessential amino acids and 1% L-glutamine. This rinse
step was followed by incubation at 37 jC for 1 h with
serum-free Dulbecco medium containing 2 mg/ml bovine
serum albumin to deplete endogenous transferrin (Tf).
This pretreatment did not affect the TEER of the cell
monolayer.
Chemicals and enzymes
Ferric chloride, human apo-transferrin, Brefeldin A, and
Colchicine were purchased from Sigma (St. Louis, MO)
and used in this study. Restriction endonucleases, T4 ligase,and proteinase K were purchased from New England
Biolabs (Beverly, Mass.).
Antibodies
A murine monoclonal antibody (mAb 5CA) against
soluble CAR (sCAR) protein was a kind gift from Dr.
Victor Krasnykh (MD Anderson Cancer Center, Houston,
TX). A murine monoclonal antibody against human trans-
ferrin protein (mAb a hTf) was purchased from US Bio-
Logical Corporation (Swampscott, MA).
Viruses
A recombinant Ad5 vector AdGL3BCMVLuc containing
a firefly luciferase-expressing cassette in place of the deleted
E1 region of the Ad genome was obtained from Dr. Masato
Yamamoto (University of Alabama at Birmingham, Bir-
mingham). These viruses had no replicative function because
of the deleted E1 gene, which is required for viral replication.
Ad was propagated on 293 cells and purified by centrifuga-
tion in CsCl gradients by a standard protocol. Virus particle
counts were determined spectrophotometrically by the meth-
od of Maizel et al. (1968) using a conversion factor of 1.1 
1012 viral particles (vp) per absorbance unit at 260 nm. To
determine the titer of infectious viral particles, the plaque
forming assay on 293 cells was performed by the method of
Mittereder et al. (1996).
Construction of recombinant plasmids
To create a construct for expression of the fusion protein
sCAR-Tf, the DNA sequence coding for a human transferrin
excluding the leading peptide (1–19 amino acids) was
amplified from the plasmid pTfR27A, which was purchased
from the ATCC, using the primers 5V-GCTAGGAT-
CCGTCCCTGATAAAACTGTGAGA, and 5V-GCTAG-
GATCCTTAGGAAAGTGCA. Both primers were
engineered in a BamHI site (underlined) in a 5V region for
cloning. The amplicon encoded the full-length human
transferrin cDNA sequence (2040 base pairs (bp)), which
was verified by automated sequence data (data not shown)
and cloned into the TA clone plasmid pCR2.1-TOPO
(Invitrogen, Carlsbad, CA). A 2040-bp DNA fragment
was removed from the Tf-TA clone with partial digestion
of the restriction endonuclease BamHI, which eliminated a
BamHI site located 272 nt (nucleotides) from the 5V end of
the transferrin cDNA.
A fusion protein sCAR-EGF clone pFBsCAR6hEGF was
a kind gift from Dr. I. Dmitriev (University of Alabama at
Birmingham, Birmingham, AL). It contained a polyhedrin
(pPolh) promoter, the human CAR ectodomain cDNA, a six
histidine marker, a short linker (SASASASAPGS), human
EGF cDNA, and a poly-A signal. The cloning site for
human EGF cDNA in pFBsCAR6hEGF was BamHI. We
successfully replaced the EGF by human transferrin cDNA
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termed pFBsCAR6hTf. After transformation of E. coli
DH5a, plasmid clones were sequenced in the region of
the insert by using the BigDye Terminator v3.1 Cycle
Sequencing Ready Reaction kit and an Applied Biosystems
3100 Genetic Analyzer (Foster City, CA). Sequence analy-
sis was performed at the Genomics Core of the Howell and
Elizabeth Heflin Center for Human Genetics of the Univer-
sity of Alabama at Birmingham. The resultant plasmid
pFBsCAR6hTf was selected. The constructed plasmid
encoding recombinant human sCAR fused with human
transferrin and tagged with an internal His6 marker that
was then used for generation of the recombinant baculovirus
genome.
Expression and purification of the histidine six-tagged
recombinant fusion protein, sCAR-Tf
The recombinant fusion protein sCAR-Tf was expressed
in High Five cells (Invitrogen) infected with the baculovirus
by the method recommended by the manufacturer. Briefly,
High Five cells were maintained in suspension culture and
infected with recombinant baculovirus at an MOI of 10 pfu/
cell. The cell suspension was harvested 72–96 h postinfec-
tion, and cells were pelleted by centrifugation. Cleared
supernatant medium was concentrated 10-fold with a Cen-
tricon Plus-20 apparatus (Millipore Corporation, Bedford,
MA) and dialyzed against phosphate-buffered saline (PBS).
Recombinant proteins were then purified by immobilized
metal iron affinity chromatography on Ni-nitrilotriacetic
acid (NTA)-Sepharose (Qiagen, Valencia, CA) using both
cell pellet and concentrated supernatant as recommended by
the manufacturer. Protein concentrations were determined
by the Bradford protein assay (Bio-Rad, Hercules, CA) with
bovine gamma globulin as the standard.
Western immunoblot analysis
For Western immunoblot analysis, a 300-ng aliquot of
sCAR, which was a kind gift from Dr. I. Dmitriev (Uni-
versity of Alabama at Birmingham, Birmingham, AL), and
20 Al of purified fusion protein sCAR-Tf were treated with
10 Al of loading buffer and subjected to sodium dodecyl
sulfate (SDS) 12% polyacrylamide gel electrophoresis
(PAGE). Following electrophoresis, the protein was trans-
ferred onto a Sequi-Blot PVDF membrane (Bio-Rad Lab-
oratories). The membrane was blocked for 1 h at room
temperature in TBS (10 mM Tris (pH 7.4), 150 mM NaCl,
2 mM EDTA) containing 5% dried milk and then washed
three times, 5 min each, at room temperature with wash
buffer (TBS plus 0.1% Tween). The membrane was incu-
bated overnight at 4 jC with either a 1:4000 dilution of a
murine monoclonal antibody (mAb 5CA) against sCAR or
1:2000 dilution of a murine monoclonal antibody (mAb a
hTf) against human transferrin protein. The membranes
were washed three times, 10 min each, at room temperaturewith wash buffer. Next, the membranes were incubated
with a 1:2000 dilution of a goat anti-mouse IgG horseradish
peroxidase-conjugated antibody (Amersham, Arlington
Heights, IL) for 1 h at room temperature. The primary
and secondary antibody was diluted with TBS plus 5%
dried milk and 0.1% Tween. After washing, the membranes
were immersed in Western LightningTM Chemilumines-
cence Reagent Plus (Perkin-Elmer Life Sciences, Boston,
MA) for 5 min at room temperature and then exposed to
Kodak X-OMAT film for from 30 s to 5 min.
ELISA
A solid-phase binding enzyme-linked immunosorbent
assay (ELISA) was performed to verify the binding function
of the fusion protein. Ad5knob was a kind gift from Joshua
Short (University of Alabama at Birmingham, Birmingham,
AL). The protein was diluted in 50 mM carbonate-bicarbon-
ate buffer (pH 9.6) to a concentration 8.0 pmol/ml, and 100-
Al aliquots were added to wells of a 96-well Nunc-Maxisorp
ELISA plate. Plates were incubvated overnight at 4 jC and
then blocked for 2 h at room temperature by the addition of
200 Al of blocking buffer (0.01 M PBS (pH 7.4), 138 mM
NaCl, 2.7 mMKCl, 0.05% Tween 20, 2% BSA) to each well.
Wells were then washed three times with washing buffer
(0.01 M PBS (pH 7.4), 138 mM NaCl, 2.7 mM KCl, 0.05%
Tween 20). Purified fusion protein sCAR-Tf from cell lysate
or medium diluted in binding buffer (0.01 M PBS (pH 7.4),
138 mM NaCl, 2.7 mM KCl, 0.05% Tween 20, 0.5% BSA)
to a concentration of 50 ng/ml was added to the wells in 100-
Al aliquots. After 1 h of incubation at room temperature, the
wells were washed three times and bound fusion protein was
detected by incubation with 1:2000 dilution of mAb antihu-
man transferrin (mAb a Tf). Following incubation at room
temperature for 1 h, the wells were washed again and
incubated with a 1:2000 dilution of goat anti-mouse IgG
conjugated with alkaline phosphate (Sigma) for 1 h. The
wells were then washed four times, and the plate was
developed with p-nitrophenyl phosphate (Sigma) as recom-
mended by the manufacturer. Plates were read in a microtiter
plate reader set at 405 nm; results are present as mean F
standard deviation (SD). The tests were performed by
excluding the primary mAb as the negative control or
background.
Internalization of Ad into Caco-2 cells via transferrin
receptor
Caco-2 cells (5  104) were plated in 12-well transwell
plates in minimum essential medium (Eagle) supplemented
with 2 mM L-glutamine, 1.5 g/l sodium bicarbonate, 0.1 mM
nonessential amino acids, and 0.1 mM sodium pyruvate, and
20% FBS; and incubated at 37 jC in a 5% CO2 atmosphere.
Basal and apical chambers contained 800 and 200 Al of
medium, respectively. When the electric resistance reached
200–300 V/cm2, the experiments were performed as follow:
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chamber medium that contained 2% FBS; (2) Group B,
before adding AdGL3BCMV, CARs on cell surfaces were
blocked with 5 Ag/ml of Ad5knob by incubating at 37 jC for
20 min; (3) Group C, CARs were blocked the same as above,
500 ng of sCAR-Tf incubated with 108 vp AdGL3BCMV in
20 Al PBS at 37 jC for 15 min was added into the basal
chamber; (4) Group D, same as group C, but 1:1000 mAb
anti-hTf was added into the mixture of sCAR-Tf and 108 vp
AdGL3BCMV for 15min at 37 jC to block sCAR-Tf binding
to TfR. After adding the Ad into the medium in the basal
chamber, cells were incubated at 37 jC overnight. The next
day, the polycarbonate filters in the transwell chamber were
cut by a razor. Cells on the filters were lysed with cell culture
lysis buffer (Promega, Madison, WI), and luciferase activity
was measured by the Luciferase Assay System of Promega
following the manufacturer’s protocol. Experiments were
performed in triplicate and luciferase activities were pre-
sented as relative light units (RLU).
Human apo-transferrin blocks the fusion protein, sCAR-Tf,
binding to TfR
Caco-2 cells (5  104) were plated in 12-well transwell
plates as outlined above. When the electric resistance of the
monolayer had reached 200–300 V/cm2, cells were blocked
with 5 Ag/ml of Ad5knob and with one of a series of human
apo-transferrin (0, 0.6, 2, 6, or 18 Ag/ml) doses at 37 jC for 20
min. A mixture of 108 vp AdGL3BCMV preincubated with
500 ng of the fusion protein sCAR-Tf was added to the basal
chamber medium containing 2% FBS. The luciferase activ-
ities of the cells were measured as before. Experiments were
performed in duplicate and luciferase activities were pre-
sented as the means. The inhibition rates were calculated
using the formula: inhibition rate = RLUwith apo-transferrin/
RLU without apo-transferrin  100%.
Iron effect on Tf binding to TfR
Caco-2 cells (5  104) were plated in 12-well transwell
plates as before. When the electric resistance of the mono-
layer had reached 200–300 V/cm2, cells were blocked with
5 Ag/ml of Ad5knob at 37 jC for 20 min. AdGL3BCMV
(108 vp) was preincubated with 500 ng of the fusion protein
sCAR-Tf, and one of a series of iron doses (0, 0.1, 1, 10, 100
AM, or 1 mM) was delivered at 37 jC for 15 min in 20 Al
PBS. Then, the mixture was added to the medium containing
2% FBS in the basal chamber. The following day, the
luciferase activities of cells were measured as discussed
above. Experiments were performed in triplicate and lucif-
erase activities were reported as the mean RLU F SD.
Ad transcytosis of Caco-2 cells
Caco-2 cells (5  104) were plated in 12-well transwell
plates as before. When the resistance of the monolayer hadreached again 200–300 V/cm2, cells were blocked with 5
Ag/ml of Ad5knob at 37 jC for 20 min. AdGL3BCMV (108
vp) was preincubated with 500 ng of the fusion protein
sCAR-Tf at 37 jC for 15 min in 20 Al PBS. The mixture
was then added to the medium containing 2% FBS in the
basal chamber. Transwell plates were incubated at 4, 15, or
37 jC, respectively, for 6 h. The medium was then collected
from the apical chamber, and the copy number of the Ad E4
gene was measured by quantitative real-time PCR. Experi-
ments were performed in triplicate and presented as the
means F SD.
The kinetic analysis of adenovirus transcytosis in Caco-
2 cells was performed by a similar strategy. When the
resistivity of the monolayer of Caco-2 cells had reached
200–300 V/cm2, cells were blocked with 5 Ag/ml of
Ad5knob at 37 jC for 20 min. AdGL3BCMV (108 vp)
was preincubated with or without 500 ng of the fusion
protein sCAR-Tf at room temperature at 37 jC in 20
Al PBS. Then, the mixture was added to the medium
containing 2% FBS in the basal chamber and the transwell
plates were incubated at 37 jC. Medium was collected
from the apical chamber at different time points (0, 10
min, 30 min, 1.5 h, 3 h, and 6 h), and the copy number of
the Ad E4 gene was measured by quantitative real-time
PCR. Experiments were performed in triplicate and the
data presented as the means F SD.
For transcytosis enhancement or inhibition, filters grown
Caco-2 monolayers were incubated with Brefeldin A (BFA,
1.6 Ag/ml), present in the basal medium for 5 h at 37 jC as
described Wan et al. (1992). Following exposure to BFA,
cells were rinsed extensively, and the chambers were refilled
with MEM. Alternatively, monolayers of Caco-2 cells were
pretreated with 10 AM of colchicine for 30 min at 4 jC
followed by a 10-min incubation at 37 jC (Morizono and
Harada, 1998). Excess drug was removed by extensive
washing. Then, 108 vp AdGL3BCMV was preincubated
with 500 ng of the fusion protein sCAR-Tf at 37 jC for 15
min in 20 Al PBS and the mixture was added to the medium
containing 2% FBS in the basal chamber. Transwell plates
were incubated 37 jC for 6 h. Then, the medium was
collected from the apical chamber, and the copy number
of the Ad E4 gene was detected by quantitative real-time
PCR as described below. Experiments were performed in
triplicate and the data were presented as the means F SD.
Quantitative real-time PCR for E4 detection
Adenovirus DNA samples were collected from the
apical medium of the transwell plates. The fluorescent
TaqMan probes and the primer pairs used for real-time
PCR in analysis of the copy number of adenovirus by
detecting the E4 gene were 5V-TGGC ATGACACTAC-
GACCAACACGATCT (probe), forward primer 5V-
GGAGTGCGCCGAGACAAC, and reverse primer 5V-
ACTACGTCCGGCGTTCCAT. They were designed using
Primer Express 1.0 (Perkin-Elmer, Foster City, CA) and
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assay, each 9 Al PCR reaction contained 3 mM MgCl2, 300
AM each of dATP, dCTP, and dGTP, 600 AM dUTP, 100
nM of forward and reverse primers, and probe, 1 U of rTth
DNA polymerase, 0.025% BSA, and RNase-free water.
Two microliters of adenovirus DNA sample was added into
each assay tube. Negative controls without template were
performed for each reaction series. Real-time PCR reaction
was carried out using a LightCycler System (Roche Mo-
lecular Biochemicals, Indianapolis, IN). Thermal cycling
conditions were 2 min at 50 jC, 30 min at 60 jC, 5 min at
95 jC, then 40 cycles of 20 s at 94 jC, and 1 min at 62 jC.
Data were analyzed with Light Cycler software.
Ad biological function assay after transcytosis
Caco-2 cells (5  104) were plated in 12-well transwell
plates as before. When the resistance of the monolayer had
reached 200–300 V/cm2, cells were blocked with 5 Ag/ml
of Ad5knob at 37 jC for 20 min. AdGL3BCMV (108 vp)
was preincubated with or without 500 ng of the fusion
protein sCAR-Tf at 37 jC for 15 min in 20 Al PBS. Then,
the mixture was added to the medium containing 2% FBS
in the basal chamber. Four hours postincubation at 37 jC,
200 Al of medium containing transcytosed adenoviruses
was collected from the apical chamber and transferred to
the 293 monolayer in 24-well plate in infection medium
containing 2% FBS. Luciferase activities were measured
from the 293 cell lysate after 24-h incubation at 37 jC with
a Luciferase Assay Kit (Promega). Experiments were
performed in triplicate and luciferase activities were pre-
sented as the RLU means F SD.Acknowledgments
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